vs
Lakeside Holding Ltd（LSH）与Rhinebeck Bancorp, Inc.（RBKB）财务数据对比。点击上方公司名可切换其他公司
Rhinebeck Bancorp, Inc.的季度营收约是Lakeside Holding Ltd的1.9倍（$13.5M vs $7.0M），Rhinebeck Bancorp, Inc.净利率更高（17.3% vs -22.6%，领先39.9%），Rhinebeck Bancorp, Inc.同比增速更快（1701.1% vs 95.0%）
莱克赛德出版社是位于美国芝加哥的出版品牌，由RR唐纳利公司运营。该社除了出版高品质书籍外，还承印邮购目录、电话号码簿、百科全书与广告宣传品，最为人熟知的是为芝加哥卡克斯顿俱乐部出版的高端版本，以及经典重印丛书《莱克赛德经典》。
Rhinebeck Bancorp, Inc.是总部位于美国纽约的区域性银行控股企业，旗下运营莱茵贝克银行，主要面向纽约哈德逊谷地区的个人消费者与中小企业提供储蓄、贷款、抵押贷款、财富管理等零售及商业金融服务。
LSH vs RBKB — 直观对比
营收规模更大
RBKB
是对方的1.9倍
$7.0M
营收增速更快
RBKB
高出1606.0%
95.0%
净利率更高
RBKB
高出39.9%
-22.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.0M | $13.5M |
| 净利润 | $-1.6M | $2.3M |
| 毛利率 | 27.2% | — |
| 营业利润率 | -21.3% | 21.7% |
| 净利率 | -22.6% | 17.3% |
| 营收同比 | 95.0% | 1701.1% |
| 净利润同比 | 18.7% | 188.0% |
| 每股收益（稀释后） | $-0.08 | $0.21 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LSHRBKB
| Q4 25 | $7.0M | $13.5M | ||
| Q3 25 | $6.1M | $14.0M | ||
| Q2 25 | $6.3M | $13.1M | ||
| Q1 25 | $3.8M | $12.8M | ||
| Q4 24 | $3.6M | $750.0K | ||
| Q3 24 | $4.1M | $773.0K | ||
| Q2 24 | — | $10.7M | ||
| Q1 24 | — | $10.4M |
净利润LSHRBKB
| Q4 25 | $-1.6M | $2.3M | ||
| Q3 25 | $-1.4M | $2.7M | ||
| Q2 25 | $-893.1K | $2.7M | ||
| Q1 25 | $-1.1M | $2.3M | ||
| Q4 24 | $-1.9M | $-2.7M | ||
| Q3 24 | $-1.3M | $-8.1M | ||
| Q2 24 | — | $975.0K | ||
| Q1 24 | — | $1.1M |
毛利率LSHRBKB
| Q4 25 | 27.2% | — | ||
| Q3 25 | 18.2% | — | ||
| Q2 25 | 26.7% | — | ||
| Q1 25 | 18.8% | — | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 12.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率LSHRBKB
| Q4 25 | -21.3% | 21.7% | ||
| Q3 25 | -20.8% | 23.9% | ||
| Q2 25 | -8.9% | 26.6% | ||
| Q1 25 | -28.2% | 22.9% | ||
| Q4 24 | -55.6% | -444.9% | ||
| Q3 24 | -32.5% | -1332.3% | ||
| Q2 24 | — | 11.8% | ||
| Q1 24 | — | 13.9% |
净利率LSHRBKB
| Q4 25 | -22.6% | 17.3% | ||
| Q3 25 | -22.2% | 19.3% | ||
| Q2 25 | -14.2% | 20.8% | ||
| Q1 25 | -28.2% | 17.9% | ||
| Q4 24 | -54.1% | -353.9% | ||
| Q3 24 | -32.7% | -1042.9% | ||
| Q2 24 | — | 9.2% | ||
| Q1 24 | — | 10.8% |
每股收益（稀释后）LSHRBKB
| Q4 25 | $-0.08 | $0.21 | ||
| Q3 25 | $-0.09 | $0.25 | ||
| Q2 25 | $-0.11 | $0.25 | ||
| Q1 25 | $-0.14 | $0.21 | ||
| Q4 24 | $-0.26 | $-0.24 | ||
| Q3 24 | $-0.18 | $-0.75 | ||
| Q2 24 | — | $0.09 | ||
| Q1 24 | — | $0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.6M | — |
| 总债务越低越好 | $2.4M | — |
| 股东权益账面价值 | $12.2M | $136.9M |
| 总资产 | $24.3M | $1.3B |
| 负债/权益比越低杠杆越低 | 0.20× | — |
8季度趋势，按日历期对齐
现金及短期投资LSHRBKB
| Q4 25 | $1.6M | — | ||
| Q3 25 | $4.5M | — | ||
| Q2 25 | $5.0M | — | ||
| Q1 25 | $1.5M | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $2.7M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
总债务LSHRBKB
| Q4 25 | $2.4M | — | ||
| Q3 25 | $2.4M | — | ||
| Q2 25 | $1.4M | — | ||
| Q1 25 | $774.2K | — | ||
| Q4 24 | $784.8K | — | ||
| Q3 24 | $589.9K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益LSHRBKB
| Q4 25 | $12.2M | $136.9M | ||
| Q3 25 | $7.0M | $133.0M | ||
| Q2 25 | $2.8M | $129.0M | ||
| Q1 25 | $749.8K | $126.0M | ||
| Q4 24 | $1.6M | $121.8M | ||
| Q3 24 | $3.6M | $122.7M | ||
| Q2 24 | — | $116.2M | ||
| Q1 24 | — | $114.3M |
总资产LSHRBKB
| Q4 25 | $24.3M | $1.3B | ||
| Q3 25 | $18.6M | $1.3B | ||
| Q2 25 | $14.4M | $1.3B | ||
| Q1 25 | $9.9M | $1.3B | ||
| Q4 24 | $9.8M | $1.3B | ||
| Q3 24 | $10.8M | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.3B |
负债/权益比LSHRBKB
| Q4 25 | 0.20× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | 1.03× | — | ||
| Q4 24 | 0.48× | — | ||
| Q3 24 | 0.16× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-453.5K | $11.7M |
| 自由现金流经营现金流 - 资本支出 | — | $10.9M |
| 自由现金流率自由现金流/营收 | — | 80.6% |
| 资本支出强度资本支出/营收 | — | 6.3% |
| 现金转化率经营现金流/净利润 | — | 5.03× |
| 过去12个月自由现金流最近4个季度 | — | $19.4M |
8季度趋势，按日历期对齐
经营现金流LSHRBKB
| Q4 25 | $-453.5K | $11.7M | ||
| Q3 25 | $-4.0M | $2.2M | ||
| Q2 25 | $-483.7K | $2.4M | ||
| Q1 25 | $-238.3K | $4.3M | ||
| Q4 24 | $-530.2K | $8.5M | ||
| Q3 24 | $-1.4M | $-3.6M | ||
| Q2 24 | — | $12.0M | ||
| Q1 24 | — | $-3.5M |
自由现金流LSHRBKB
| Q4 25 | — | $10.9M | ||
| Q3 25 | — | $2.0M | ||
| Q2 25 | $-497.4K | $2.2M | ||
| Q1 25 | — | $4.2M | ||
| Q4 24 | $-560.5K | $7.7M | ||
| Q3 24 | $-1.4M | $-3.6M | ||
| Q2 24 | — | $11.8M | ||
| Q1 24 | — | $-3.7M |
自由现金流率LSHRBKB
| Q4 25 | — | 80.6% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | -7.9% | 17.2% | ||
| Q1 25 | — | 32.8% | ||
| Q4 24 | -15.6% | 1023.9% | ||
| Q3 24 | -34.5% | -469.0% | ||
| Q2 24 | — | 111.1% | ||
| Q1 24 | — | -36.0% |
资本支出强度LSHRBKB
| Q4 25 | — | 6.3% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | 0.2% | 1.4% | ||
| Q1 25 | 0.0% | 0.9% | ||
| Q4 24 | 0.8% | 105.5% | ||
| Q3 24 | 0.1% | 6.3% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 2.3% |
现金转化率LSHRBKB
| Q4 25 | — | 5.03× | ||
| Q3 25 | — | 0.83× | ||
| Q2 25 | — | 0.89× | ||
| Q1 25 | — | 1.89× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.27× | ||
| Q1 24 | — | -3.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LSH
| Transferred Over Time | $4.6M | 65% |
| Distribution Of Pharmaceutical Products | $2.4M | 35% |
RBKB
暂无分部数据
